SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-013923
Filing Date
2020-06-02
Accepted
2020-06-02 16:12:57
Documents
3
Period of Report
2020-06-26
Effectiveness Date
2020-06-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0620_delmarpharma.htm DEF 14A 815837
2 GRAPHIC proxy_001.jpg GRAPHIC 767259
3 GRAPHIC proxy_002.jpg GRAPHIC 852047
  Complete submission text file 0001213900-20-013923.txt   3011003
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-37823 | Film No.: 20937098
SIC: 2834 Pharmaceutical Preparations